Lpl Financial LLC Kodiak Sciences Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $180,942 - $287,560	-2,238 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $183,448 - $239,331	2,238 New	2,238 $215,000
Q2 2021 Aug 13, 2021	SELL	$77.2 - $126.54 $141,044 - $231,188	-1,827 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$110.45 - $164.47 $662 - $986	6 Added 0.33%	1,827 $207,000
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $110,680 - $280,488	1,821 New	1,821 $268,000

109

40.9M

28.4K

21.2K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $183M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.